mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.5 |